Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05229055

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

Conditions: Acute Pain

Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: PHASE2, PHASE3
Enrollment: 1000
Sponsor: University of Monastir

Location: university of Monastir Monastir

Summary

Pain is the most common complaint for emergency department (ED) visit. Intranasal ketamine has been shown to provide rapid, well-tolerated, effective analgesia to emergency department (ED) patients with acute pain. few trials have studied ketamine infusion subcutaneously for pain management in trauma patients.

Eligibility Criteria

Inclusion Criteria: * • Patients who presented to the ED with acute limb trauma pain with a visual analgesic scale (VAS) of 5 or more on a standard 11 point (0-10). * Pain was considered traumatic if it is reported as appearing immediately after the trauma and no anterior pain was described in the same limb. Exclusion Criteria: * Pregnancy/Breastfeeding * altered mental status (GCS\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05229055). StuddyBuddy aggregates publicly available trial information.